412132
Position
Chairman
Company
BayHelix
Bio
Dr. Shi has 25 years of experience in life science commercial operations, business development and investment. He currently focuses on investing in diagnostics and medical devices in China. He has led commercial operations at QIAGEN in Asia Pacific for ten years. Previously he was either a founding member of or held senior positions at Aura Partners, Bridge Pharmaceuticals, Genospectra, and A. M. Pappas & Associates. He was also a faculty member at National University of Singapore, School of Medicine and a cancer research scientist at Merck & Co. Dr. Shi currently serves as Deputy Secretary-General of Chinese In-Vitro Diagnostics Industry Association and is a member of the China Board and Executive Committee of the Advanced Medical Technology Association (AdvaMed). He also serves on the board of Bayhelix, a global association of Chinese life science business executives. Dr. Shi obtained a Ph.D. and an MS degree from the University of Rochester, New York, and a BS from the University of Science and Technology of China.
Agenda
emergingopp_icon

Emerging Opportunities in Global Markets

11:45 AM–5:00 PM Jun 4, 2018

Room 253ABC, Level 2

Katherine AndersenHead of Healthcare Corporate Finance and East/Central Life Science atSilicon Valley Bank Michael ChanSenior VP atHKEX Helen ChenManaging Director, Head of L.E.K. China and Asia Life Sciences atL.E.K. Consulting Tony ChenPartner atJones Day Shanghei Joseph DamondExecutive Vice President, International Affairs atBiotechnology Innovation Organization Yuan-Hua DingExecutive Director and Head of External Science & Innovation atPfizer Monica H.Director, International Affairs atBiotechnology Innovation Organization Edward HuChief Financial Officer and Chief Investment Officers atWuXi AppTec Kewen JinManaging Partner atSerica Partners Alex JungPartner/Managing DIrector atEY-Parthenon Wei LiFounding Partner at6 Dimensions Capital Micah MackisonSenior VP for Corporate Development and Strategy atAssembly Biosciences Wendy PanPartner atSidley Donghui QinDirector of Innovation atFerring Pharmaceuticals Greg ScottFounder and Chairman atChinaBIO Group Victor ShiChairman atBayHelix Alan TurleyDeputy Assistant Secretary for China atU.S. Department of Commerce Jonathan WangSenior VP and Head of Business Development atZai Lab Lijun WuChief Scientific Officer and Senior VP R&D, Fosun Pharma USA atFosun Pharma USA Haishan XiongSenior Vice President for Business Development atFountain Medical Development, Ltd GE YanfengDirector-General of the Research Department of Social Development atDevelopment Research Center of the State Council (DRC) Debra YuManaging Director atChina Renaissance Securities (US) Inc.
Interests
None yet.